365 related articles for article (PubMed ID: 11169511)
1. Expression of telomerase genes correlates with telomerase activity in human colorectal carcinogenesis.
Yan P; Saraga EP; Bouzourene H; Bosman FT; Benhattar J
J Pathol; 2001 Jan; 193(1):21-6. PubMed ID: 11169511
[TBL] [Abstract][Full Text] [Related]
2. Telomerase activity and expression of telomerase genes in squamous dysplasia and squamous cell carcinoma of the esophagus.
Yu HP; Xu SQ; Lu WH; Li YY; Li F; Wang XL; Su YH
J Surg Oncol; 2004 May; 86(2):99-104. PubMed ID: 15112252
[TBL] [Abstract][Full Text] [Related]
3. Expression of telomerase genes in thyroid carcinoma.
Hoang-Vu C; Boltze C; Gimm O; Poremba C; Dockhorn-Dworniczak B; Köhrle J; Rath FW; Dralle H
Int J Oncol; 2002 Aug; 21(2):265-72. PubMed ID: 12118320
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of human telomerase reverse transcriptase in human colorectal carcinomas by in situ hybridization.
Kammori M; Kanauchi H; Nakamura K; Kawahara M; Weber TK; Mafune K; Kaminishi M; Takubo K
Int J Oncol; 2002 Jan; 20(1):15-21. PubMed ID: 11743637
[TBL] [Abstract][Full Text] [Related]
5. Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer.
Takihana Y; Tsuchida T; Fukasawa M; Araki I; Tanabe N; Takeda M
Int J Urol; 2006 Apr; 13(4):401-8. PubMed ID: 16734859
[TBL] [Abstract][Full Text] [Related]
6. Telomerase activity and hTERT mRNA in development and progression of adenoma to colorectal cancer.
Kanamaru T; Tanaka K; Kotani J; Ueno K; Yamamoto M; Idei Y; Hisatomi H; Takeyama Y
Int J Mol Med; 2002 Aug; 10(2):205-10. PubMed ID: 12119560
[TBL] [Abstract][Full Text] [Related]
7. Telomerase in (pre)neoplastic cervical disease.
Wisman GB; De Jong S; Meersma GJ; Helder MN; Hollema H; de Vries EG; Keith WN; van der Zee AG
Hum Pathol; 2000 Oct; 31(10):1304-12. PubMed ID: 11070123
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of hTERT mRNA expression in colorectal cancer.
Niiyama H; Mizumoto K; Sato N; Nagai E; Mibu R; Fukui T; Kinoshita M; Tanaka M
Am J Gastroenterol; 2001 Jun; 96(6):1895-900. PubMed ID: 11419845
[TBL] [Abstract][Full Text] [Related]
9. Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma.
Gertler R; Rosenberg R; Stricker D; Werner M; Lassmann S; Ulm K; Nekarda H; Siewert JR
Cancer; 2002 Nov; 95(10):2103-11. PubMed ID: 12412163
[TBL] [Abstract][Full Text] [Related]
10. Expression of telomerase activity, telomerase RNA component and telomerase catalytic subunit gene in lung cancer.
Chen W; Xiong X; Zhou H; Zhou Q
Chin Med J (Engl); 2002 Feb; 115(2):290-2. PubMed ID: 11940351
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
Hayashidani Y; Hiyama E; Murakami Y; Sueda T
Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061
[TBL] [Abstract][Full Text] [Related]
12. Immuno-histochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor and non-tumor tissue sections.
Tahara H; Yasui W; Tahara E; Fujimoto J; Ito K; Tamai K; Nakayama J; Ishikawa F; Tahara E; Ide T
Oncogene; 1999 Feb; 18(8):1561-7. PubMed ID: 10102626
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of hTERT is associated with dysplastic cell transformation during human oral carcinogenesis in situ.
Kim HR; Christensen R; Park NH; Sapp P; Kang MK; Park NH
Clin Cancer Res; 2001 Oct; 7(10):3079-86. PubMed ID: 11595698
[TBL] [Abstract][Full Text] [Related]
14. Detection of telomerase RNA in the plasma of patients with breast cancer, malignant melanoma or thyroid cancer.
Novakovic S; Hocevar M; Zgajnar J; Besic N; Stegel V
Oncol Rep; 2004 Jan; 11(1):245-52. PubMed ID: 14654933
[TBL] [Abstract][Full Text] [Related]
15. Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity.
Ducrest AL; Amacker M; Mathieu YD; Cuthbert AP; Trott DA; Newbold RF; Nabholz M; Lingner J
Cancer Res; 2001 Oct; 61(20):7594-602. PubMed ID: 11606399
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human telomerase reverse transcriptase by nonsteroidal antiinflammatory drugs in colon carcinoma.
He H; Xia HH; Wang JD; Gu Q; Lin MC; Zou B; Lam SK; Chan AO; Yuen MF; Kung HF; Wong BC
Cancer; 2006 Mar; 106(6):1243-9. PubMed ID: 16444744
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues.
Fan Y; Liu Z; Fang X; Ge Z; Ge N; Jia Y; Sun P; Lou F; Björkholm M; Gruber A; Ekman P; Xu D
Clin Cancer Res; 2005 Jun; 11(12):4331-7. PubMed ID: 15958614
[TBL] [Abstract][Full Text] [Related]
18. Expression of the human telomerase reverse transcriptase is not related to telomerase activity in normal and malignant renal tissue.
Rohde V; Sattler HP; Bund T; Bonkhoff H; Fixemer T; Bachmann C; Lensch R; Unteregger G; Stoeckle M; Wullich B
Clin Cancer Res; 2000 Dec; 6(12):4803-9. PubMed ID: 11156238
[TBL] [Abstract][Full Text] [Related]
19. Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression.
Chen CJ; Tsai NM; Liu YC; Ho LI; Hsieh HF; Yen CY; Harn HJ
Eur J Surg Oncol; 2002 Apr; 28(3):225-34. PubMed ID: 11944954
[TBL] [Abstract][Full Text] [Related]
20. Quantitative assessment of telomerase activity and human telomerase reverse transcriptase messenger RNA levels in pancreatic juice samples for the diagnosis of pancreatic cancer.
Ohuchida K; Mizumoto K; Ogura Y; Ishikawa N; Nagai E; Yamaguchi K; Tanaka M
Clin Cancer Res; 2005 Mar; 11(6):2285-92. PubMed ID: 15788678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
